ClinicalTrials.Veeva

Menu

Efficacy of High-precision Transcranial Direct Current Stimulation on Anxiety Disorders

N

Nanjing Medical University

Status

Not yet enrolling

Conditions

Anxiety Disorders
High-definition Transcranial Direct Current Stimulation

Treatments

Other: High-definition transcranial direct current stimulation
Other: High-definition transcranial direct current stimulation pseudo-stimulation control group

Study type

Interventional

Funder types

Other

Identifiers

NCT06529341
123201004258009355

Details and patient eligibility

About

  1. Current research has found that tDCS has a positive effect on improving the negative attention bias of AD patients, and this study uses HD-tDCS intervention to improve the cognitive function and neural mechanisms of AD patients in the OFC to provide a theoretical basis for AD neural mechanism research. Verify Hypothesis 1: HD-tDCS cathodal stimulation of the left OFC reduces the excitability of this region, modulates its connectivity with the attentional function network, and thus changes the emotional experience of social threat.
  2. Currently, there is no consensus on the stimulation parameters for tDCS in the treatment of AD, and more evidence is needed to prove and explore. It is hoped that the HD-tDCS intervention protocol will become an effective treatment method for improving cognitive function and clinical symptoms in AD patients. Hypothesis 2: The HD-tDCS with intensified stimulation parameters (2mA, twice a day, with a 20-minute interval, for 5 consecutive days) has an impact on the main and secondary clinical variables of AD patients.

Enrollment

60 estimated patients

Sex

All

Ages

20 to 50 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Meet the DSM-5 AD diagnostic criteria;
  2. The Chinese version of the Brief International Neuropsychiatric Interview (MINI) screening meets the diagnosis;
  3. Age: 18-55 years old;
  4. The patient participated voluntarily, obtained the consent of the family members, and signed the informed consent form;
  5. Scale score criteria: 14 points on the Hamilton Anxiety Scale (HAMA) and 17 points on the Hamilton Depression Scale (HAMD).

Exclusion criteria

  1. Neurological diseases or other psychiatric disorders;
  2. severe somatic diseases;
  3. received medical treatment including medication, psychotherapy, electroconvulsive therapy, and physical therapy within the first half months of enrollment;
  4. tDCS examination contraindications, such as intracranial metal or electronic implants, skull plate, or other skull implants.
  5. Pregnancy and lactation.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

60 participants in 2 patient groups

High-definition transcranial direct current stimulation
Experimental group
Description:
HD-tDCS stimulated AD left OFC (2 mA, 20 minutes, cathode electrode placed in the Fp 1 area, and the remaining four positive electrodes placed AF3, AF7, Afz, Fpz, forming a circular 41 focused electric field mode for stimulation, twice a day, 20 minutes interval for 5 days)
Treatment:
Other: High-definition transcranial direct current stimulation
High-definition transcranial direct current stimulation pseudo-stimulation control group
Active Comparator group
Description:
The treatment parameters of the electrode were the same as the test group, the stimulation current rose to the same 2 mA current in the test group within 30 seconds, and the pre-stimulation for 1 minute, then gradually to 0 mA.
Treatment:
Other: High-definition transcranial direct current stimulation pseudo-stimulation control group

Trial contacts and locations

1

Loading...

Central trial contact

Chun Wang

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems